about
Overexpression of cytochrome C by a recombinant rabies virus attenuates pathogenicity and enhances antiviral immunity.Attenuated rabies virus activates, while pathogenic rabies virus evades, the host innate immune responses in the central nervous system.A single amino acid change in rabies virus glycoprotein increases virus spread and enhances virus pathogenicity.Overexpression of tumor necrosis factor alpha by a recombinant rabies virus attenuates replication in neurons and prevents lethal infection in miceSequencing and molecular characterization of CTNCEC25, a China fixed rabies virus vaccine strain CTN-1 adapted to primary chicken embryo cells.Overexpression of the rabies virus glycoprotein results in enhancement of apoptosis and antiviral immune response.A single immunization with a rhabdovirus-based vector expressing severe acute respiratory syndrome coronavirus (SARS-CoV) S protein results in the production of high levels of SARS-CoV-neutralizing antibodiesSecond-generation rabies virus-based vaccine vectors expressing human immunodeficiency virus type 1 gag have greatly reduced pathogenicity but are highly immunogenicNew approaches to the prevention and eradication of rabies.Development in Immunoprophylaxis against Rabies for Animals and HumansComplete Genome Sequence of a Rabies Virus Isolate from a Ferret Badger (Melogale moschata) in Jiangxi, China.A recombinant rabies virus encoding two copies of the glycoprotein gene confers protection in dogs against a virulent challenge.Extensive attenuation of rabies virus by simultaneously modifying the dynein light chain binding site in the P protein and replacing Arg333 in the G protein.Reverse genetics of rabies virus: new strategies to attenuate virus virulence for vaccine development.Characterization of recombinant rabies virus carrying double glycoprotein genes.Multigenic relation to the attenuation of rabies virus.Characterization of M gene-deficient rabies virus with advantages of effective immunization and safety as a vaccine strain.An inactivated recombinant rabies CVS-11 virus expressing two copies of the glycoprotein elicits a higher level of neutralizing antibodies and provides better protection in mice.Molecular characterization of three ferret badger (Melogale moschata) rabies virus isolates from Jiangxi province, China.Construction and immunogenicity of a recombinant pseudotype baculovirus expressing the glycoprotein of rabies virus in mice.Pathogenicity and Immunogenicity of Recombinant Rabies Viruses Expressing the Lagos Bat Virus Matrix and Glycoprotein: Perspectives for a Pan-Lyssavirus VaccineProtection Against CNS-Targeted Rabies Virus Infection is Dependent upon Type-1 Immune Mechanisms Induced by Live-Attenuated Rabies Vaccines
P2860
Q33848911-2251B2C4-416E-4068-A007-AADCC5BF8B0CQ33984263-B90A19E3-28BF-4985-9A3C-3F87662B2EBFQ34124054-1DCB62EB-7093-4ED9-9C4A-5CD5CA922EA5Q34228539-330D4019-A5EE-4476-A1A8-8BDBFE0329EEQ34334103-B171E1C6-3B74-42C4-B962-CF8FC4CEC437Q34334320-1788608B-5D8A-4B11-825F-01F3EBFB304DQ34338054-018C6A44-BA37-4797-BF05-E0E4D552A964Q34461764-1B8C171F-4BA7-4F7D-8BCA-9C48FBD1F92FQ35194187-080BE27B-06F6-4A9A-9808-068EA3FD875AQ36571288-1959C97A-8F6D-4136-A767-9A29E7FABB6FQ37000348-B645825E-0E49-4135-B713-01A021966CB7Q37548524-9F98BB55-3E42-41F1-AD06-DECC440E360DQ38295138-89C871C5-983A-4187-A2FA-8F485C3ABF04Q39004337-21F86F25-9837-473C-A542-9F7682BC4419Q40302342-4DED5195-5759-404E-9184-2B806573B04FQ40326282-FAE8A76B-8D42-4D00-A1EE-AD8B74A59677Q40348750-DAD181F3-DBFA-45B7-A5CF-EC9D0C8F3E09Q42227995-D960B2CA-3CDF-4848-A5AB-BC73FD9B39B9Q42230514-4ACABFB4-BD2B-410A-A076-7389D310142DQ44614443-9CF63D33-70A1-41B8-A50B-1C478439849AQ56967894-698CF3D5-43CF-4CDE-BBCA-EF843B51E403Q57152975-19BC92EB-C0CE-4D10-A4A2-1FDBBD96D41D
P2860
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Genetic engineering of live rabies vaccines.
@en
Genetic engineering of live rabies vaccines.
@nl
type
label
Genetic engineering of live rabies vaccines.
@en
Genetic engineering of live rabies vaccines.
@nl
prefLabel
Genetic engineering of live rabies vaccines.
@en
Genetic engineering of live rabies vaccines.
@nl
P2093
P1433
P1476
Genetic engineering of live rabies vaccines.
@en
P2093
Dietzschold B
McGettigan JP
Morimoto K
Schnell MJ
P304
P356
10.1016/S0264-410X(01)00064-0
P407
P577
2001-05-01T00:00:00Z